People: Zoetis Inc (ZTS.N)
ZTS.N on New York Stock Exchange
30.74USD
2:32pm EDT
30.74USD
2:32pm EDT
Price Change (% chg)
$0.58 (+1.92%)
$0.58 (+1.92%)
Prev Close
$30.16
$30.16
Open
$30.01
$30.01
Day's High
$30.74
$30.74
Day's Low
$29.91
$29.91
Volume
434,639
434,639
Avg. Vol
1,699,440
1,699,440
52-wk High
$35.40
$35.40
52-wk Low
$28.97
$28.97
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Michael McCallister |
60 | 2013 | Non-Executive Chairman of the Board |
Juan Alaix |
61 | 2012 | Chief Executive Officer, Director |
Richard Passov |
44 | 2012 | Chief Financial Officer, Executive Vice President |
Roxanne Lagano |
48 | 2012 | Chief Human Resource Officer, Executive Vice President |
Heidi Chen |
46 | 2012 | Executive Vice President, General Counsel, Corporate Secretary |
Sandra Beaty |
55 | 2012 | Executive Vice President - Corporate Affairs |
Alejandro Bernal |
40 | 2012 | Executive Vice President and Area President of the Europe, Africa and Middle East region |
Catherine Knupp |
52 | 2012 | Executive Vice President and President of Research and Development |
Joyce Lee |
40 | 2012 | Executive Vice President and Area President of the Canada and Latin America region |
Clinton Lewis |
46 | 2012 | Executive Vice President and President of U.S. Operations |
Kristin Peck |
41 | 2012 | Executive Vice President and Group President |
Stefan Weiskopf |
53 | 2012 | Executive Vice President and Area President of the Asia Pacific, Australia and New Zealand |
Frank D'Amelio |
55 | 2013 | Director |
Sanjay Khosla |
61 | 2013 | Independent Director |
Gregory Norden |
55 | 2013 | Independent Director |
Robert Scully |
63 | 2013 | Independent Director |
William Steere |
2013 | Independent Director |
Biographies
| Name | Description |
|---|---|
Michael McCallister |
Mr. Michael B. McCallister is Non-Executive Chairman of the Board of Zoetis Inc. Mr. McCallister has been the Chairman of the Board of Directors of Humana Inc. since 2010. Mr. McCallister joined Humana Inc. in 1974 and has held various positions, including Chief Executive Officer from 2000 until December 31, 2012. Humana Inc. is a healthcare company that offers a wide range of insurance products and health and wellness services. Mr. McCallister currently serves on the Board of Directors of Fifth Third Bancorp and Bellarmine University. Mr. McCallister also served on the Board of Directors of National City Corporation until its merger with PNC Financial Services Group in December 2008 as well as on the Board of Directors and as Chairman of the Health and Retirement Task Force of the Business Roundtable. |
Juan Alaix |
Mr. Juan Ramon Alaix is Chief Executive Officer, Director of Zoetis Inc. He is President of Pfizer's animal health business unit since 2006. Mr. Alaix joined Pfizer in 2003 and held various positions, including Regional President of Central/Southern Europe for Pfizer's pharmaceutical business. Mr. Alaix held various positions, including Market President, Spain at Pharmacia Spain from 1998 until its acquisition by Pfizer in 2003. Mr. Alaix currently serves as President and as a member of the Board of Directors and the executive committee of the International Federation for Animal Health. |
Richard Passov |
Mr. Richard A. Passov is Chief Financial Officer, Executive Vice President of Zoetis Inc. Mr. Passov joined Pfizer in 1997 and served as Senior Vice President and Treasurer for Pfizer from 2001 to 2012 and served as Assistant Treasurer from 1997 to 2001. |
Roxanne Lagano |
Ms. Roxanne Lagano is Chief Human Resource Officer, Executive Vice President of Zoetis Inc. Ms. Lagano joined Pfizer in 1997 and held various positions, including Senior Vice President, Pfizer Global Compensation, Benefits and Wellness and Senior Director, Business Transactions, Pfizer Worldwide Human Resources. |
Heidi Chen |
Mr. Heidi C. Chen is Executive Vice President, General Counsel, Corporate Secretary of Zoetis Inc. He served as Vice President and Chief Counsel of Pfizer's animal health business unit since 2009. Ms. Chen joined Pfizer in 1998 and held various legal and compliance positions, including lead counsel for Pfizer's Established Products business unit. |
Sandra Beaty |
Ms. Sandra J. Beaty is Executive Vice President - Corporate Affairs of Zoetis Inc. Ms. Beaty joined Pfizer in 1996 and held various positions, including Senior Vice President of Public Affairs and Chief of Staff to the former Pfizer Chairman and CEO. |
Alejandro Bernal |
Mr. Alejandro Bernal is Executive Vice President and Area President of the Europe, Africa and Middle East region of Zoetis Inc. He is Area President of that region for Pfizer's animal health business unit since 2010. Mr. Bernal joined Pfizer in 2000 and held various positions, including Area President Canada and Latin America region; Regional Director of Southwest and Central Latin America; Division Director for Central America and Colombia; Swine and Poultry Team Leader for Mexico; and Swine Product Manager for Northern Latin America for Pfizer's animal health business unit. |
Catherine Knupp |
Dr. Catherine A. Knupp is Executive Vice President and President of Research and Development of Zoetis Inc. Dr. Catherine serves as Vice President of Pfizer's Veterinary Medicine Research and Development since September 2005. Dr. Knupp joined Pfizer in July 2001 and held various positions, including Vice President of Pfizer's Michigan laboratories for Pharmacokinetics, Dynamics and Metabolism. |
Joyce Lee |
Ms. Joyce J. Lee is Executive Vice President and Area President of the Canada and Latin America region of Zoetis Inc. Ms. Lee serves as Area President of the same region for Pfizer's animal health business unit since December 2010. Ms. Lee joined Pfizer in 2003 with the acquisition of Pharmacia and held various positions, including Vice President of Global Poultry and Vice President of Global Business Technology for Pfizer's animal health business unit. |
Clinton Lewis |
Mr. Clinton A. Lewis, Jr., is Executive Vice President and President of U.S. Operations of Zoetis Inc. He serves as President of U.S. Operations for Pfizer's animal health business unit since 2007. Mr. Lewis joined Pfizer in 1988 and held various positions across sales, marketing and general management including Senior Vice President of Sales, U.S.; General Manager, Pfizer Caribbean; and General Manager, U.S. Anti-Infectives. |
Kristin Peck |
Ms. Kristin C. Peck is Executive Vice President and Group President of Zoetis Inc. Ms. Peck joined Pfizer in 2004 and held various positions, including Executive Vice President, Worldwide Business Development and Innovation; Senior Vice President of Worldwide Business Development, Strategy and Innovation; Senior Vice President, Worldwide Strategy and Innovation; Vice President, Strategic Planning; Chief of Staff to the Vice Chairman; and Senior Director, Strategic Planning. Ms. Peck also served as a member of Pfizer's Executive Leadership Team. |
Stefan Weiskopf |
Mr. Stefan Weiskopf is Executive Vice President and Area President of the Asia Pacific, Australia and New Zealand of Zoetis Inc. Mr. Weiskopf joined Pfizer in 1988 and held positions, including Division Director Animal Health for Germany, Austria and Switzerland. |
Frank D'Amelio |
Mr. Frank A. D'Amelio is Director of Zoetis Inc. Frank A. D'Amelio has served as a member of the company board since July 2012 and as Executive Vice President, Chief Financial Officer and Business Operations for Pfizer since December 2010. Mr. D'Amelio joined Pfizer in September 2007 and held various positions, including Senior Vice President and Chief Financial Officer. From November 2006 to August 2007, Mr. D'Amelio held the position of Senior Executive Vice President of Integration and Chief Administrative Officer at Alcatel-Lucent, S.A. Mr. D'Amelio currently serves on the Board of Directors of Humana Inc. and is Chair of the Humana Inc. Audit Committee. Mr. D'Amelio also currently serves as a member of the National Advisory Board of JPMorgan Chase & Co. |
Sanjay Khosla |
Mr. Sanjay Khosla has been appointed as Independent Director of Zoetis Inc., effective June 27, 2013. Mr. Khosla brings more than 35 years of international business experience from his career with food, beverage and consumer product leaders such as Mondelez, Kraft and Unilever, where he managed various business units, particularly in developing markets. He also has animal health experience from his three-year tenure as Managing Director of Fonterra Brands and Food Service, a multi-national dairy cooperative based in New Zealand. Mr. Khosla serves on the board of Best Buy, Inc., a specialty retailer of consumer electronics, personal computers, entertainment software and appliances, and on the board of NIIT, Ltd., a company involved in technology-related educational services. |
Gregory Norden |
Mr. Gregory Norden is Independent Director of Zoetis Inc., January 2013. Mr. Norden is the Managing Director of G9 Capital Group LLC which invests in early stage ventures and provides corporate finance advisory services. From 1989 to 2010, Mr. Norden held various senior positions with Wyeth/American Home Products, most recently as Wyeth's Senior Vice President and Chief Financial Officer (from 2007 to 2010). Prior to this role, Mr. Norden was Executive Vice President and Chief Financial Officer of Wyeth Pharmaceuticals. Prior to his affiliation with Wyeth, Mr. Norden served as Audit Manager at Arthur Andersen & Co. Mr. Norden also serves on the Board of Directors of Welch Allyn, a provider of medical diagnostic equipment, and NanoString Technologies, a provider of life science tools for translational research and development of molecular diagnostic products. Mr. Norden is a former director of Human Genome Sciences, Inc., where he served until 2012. |
Robert Scully |
Mr. Robert W. Scully has been appointed as Independent Director of Zoetis Inc., effective June 27, 2013. Mr. Scully served as a member of the office of the chairman of Morgan Stanley focusing on the firm's key clients until January 2009, when he retired after nearly 35 years in the financial services industry. Mr. Scully brings global management experience, business development knowledge and investor insights to the Zoetis board. In addition to his roles at Morgan Stanley from 1996 through 2008, Mr. Scully held various positions in other banking and financial services companies throughout his career. He currently serves on the board of Kohlberg Kravis Roberts & Company (KKR), a global investment management firm. |
William Steere |
Mr. William C. Steere, Jr., is Independent Director of Zoetis Inc., since January 2013. Mr. Steere has been Chairman Emeritus of Pfizer since July 2001. Mr. Steere joined Pfizer in 1959 and held various positions, including Chief Executive Officer from 1991 until 2000; Chairman of the Board of Directors from 1992 until 2001; and member of the Board of Directors until 2011. Mr. Steere is currently on the Board of Directors of Health Management Associates, Inc. Mr. Steere also served on the boards of directors of Dow Jones & Company, Inc. until 2007 and MetLife, Inc. until 2010. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Michael McCallister |
-- |
Juan Alaix |
2,501,630 |
Richard Passov |
1,801,420 |
Roxanne Lagano |
-- |
Heidi Chen |
-- |
Sandra Beaty |
-- |
Alejandro Bernal |
-- |
Catherine Knupp |
1,308,000 |
Joyce Lee |
-- |
Clinton Lewis |
1,383,400 |
Kristin Peck |
2,278,410 |
Stefan Weiskopf |
-- |
Frank D'Amelio |
-- |
Sanjay Khosla |
-- |
Gregory Norden |
-- |
Robert Scully |
-- |
William Steere |
-- |
As Of 30 Dec 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Michael McCallister |
0 | 0 |
Juan Alaix |
0 | 0 |
Richard Passov |
0 | 0 |
Roxanne Lagano |
0 | 0 |
Heidi Chen |
0 | 0 |
Sandra Beaty |
0 | 0 |
Alejandro Bernal |
0 | 0 |
Catherine Knupp |
0 | 0 |
Joyce Lee |
0 | 0 |
Clinton Lewis |
0 | 0 |
Kristin Peck |
0 | 0 |
Stefan Weiskopf |
0 | 0 |
Frank D'Amelio |
0 | 0 |
Sanjay Khosla |
0 | 0 |
Gregory Norden |
0 | 0 |
Robert Scully |
0 | 0 |
William Steere |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
PFIZER INC |
400,985,000 | $0.00 |
WEISKOPF STEFAN |
1,386 | $0.00 |
PFIZER INC |
400,985,000 | $0.00 |
STEERE WILLIAM C JR |
4,500 | $26.00 |
CHEN HEIDI C |
2,500 | $26.00 |
GERMANO GENO J |
5,000 | $26.00 |
LEE JOYCE J |
2,000 | $26.00 |
D AMELIO FRANK A |
5,000 | $26.00 |
GIORDANO DOUGLAS E |
5,000 | $26.00 |
LAGANO ROXANNE |
2,000 | $26.00 |
HILL CHARLES H |
5,000 | $26.00 |
PFIZER INC |
12,915,000 | $0.00 |
BEATY SANDRA J |
2,000 | $26.00 |
LEWIS CLINTON A JR |
500 | $26.00 |
KNUPP CATHERINE A |
1,000 | $26.00 |
NORDEN GREGORY |
3,000 | $26.00 |
PFIZER INC |
99,015,000 | $0.00 |
SCHULMAN AMY W |
5,000 | $26.00 |
WEISKOPF STEFAN |
320 | $31.14 |

